Home › Osteosarcoma › Michigan › Ann Arbor
Osteosarcoma clinical trials in Ann Arbor, MI
3 studies for Osteosarcoma are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RecruitingPhase 2
- C S Mott Children's Hospital, Ann Arbor
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- C S Mott Children's Hospital, Ann Arbor
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RecruitingPhase 3
- C S Mott Children's Hospital, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
Osteosarcoma trials in other cities
- St. Louis, MO10 studies
- Memphis, TN10 studies
- Atlanta, GA10 studies
- Boston, MA9 studies
- Mountain View, CA8 studies
- Houston, TX7 studies
- Chicago, IL7 studies
- Los Angeles, CA7 studies
- Birmingham, AL7 studies
- New York City, NY6 studies
- Cincinnati, OH6 studies
- Washington, DC6 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Breast Cancer26 studies
- Cancer (all types)26 studies
- Non-Small Cell Lung Cancer25 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.